{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:07Z","timestamp":1792174987763,"version":"4.4.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12022-020-09658-7","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T02:35:00Z","timestamp":1610505300000},"page":"134-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?"],"prefix":"10.1007","volume":"32","author":[{"given":"Thomas G.","family":"Papathomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik P. D.","family":"Suurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-564X","authenticated-orcid":false,"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"9658_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000377703","volume":"101","author":"TE Osinga","year":"2015","unstructured":"Osinga TE, Korpershoek E, de Krijger RR, et al (2015) Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue. Neuroendocrinology 101:289\u2013295. https:\/\/doi.org\/10.1159\/000377703","journal-title":"Neuroendocrinology"},{"key":"9658_CR2","first-page":"18","volume-title":"Boffetta P, Hainaut PBT-E of C","author":"TG Papathomas","year":"2019","unstructured":"Papathomas TG, Giordano TJ, Maher ER, Tischler AS (2019) Adrenal Glands Tumors: Pathology and Genetics. In: Boffetta P, Hainaut PBT-E of C (Third E (eds). Academic Press, Oxford, pp 18\u201329"},{"key":"9658_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccell.2017.01.009","volume":"31","author":"PLM Dahia","year":"2017","unstructured":"Dahia PLM (2017) Pheochromocytomas and Paragangliomas, Genetically Diverse and Minimalist, All at Once! Cancer Cell 31:159\u2013161. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.009","journal-title":"Cancer Cell"},{"key":"9658_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/gim.2014.162","volume":"17","author":"L Evenepoel","year":"2015","unstructured":"Evenepoel L, Papathomas TG, Krol N, et al (2015) Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med 17:610\u2013620. https:\/\/doi.org\/10.1038\/gim.2014.162","journal-title":"Genet Med"},{"key":"9658_CR5","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1210\/jc.2019-00175","volume":"104","author":"C Cardot-Bauters","year":"2019","unstructured":"Cardot-Bauters C, Carnaille B, Aubert S, et al (2019) A Full Phenotype of Paraganglioma Linked to a Germline SDHB Mosaic Mutation. J Clin Endocrinol Metab 104:3362\u20133366. https:\/\/doi.org\/10.1210\/jc.2019-00175","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona J, Ta\u00efeb D, Pacak K (2017) New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev 38:489\u2013515. https:\/\/doi.org\/10.1210\/er.2017-00062","journal-title":"Endocr Rev"},{"key":"9658_CR7","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein L, Khare S, Wubbenhorst B, et al (2015) Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun 6:6140. https:\/\/doi.org\/10.1038\/ncomms7140","journal-title":"Nat Commun"},{"key":"9658_CR8","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"Castro-Vega LJ, Letouz\u00e9 E, Burnichon N, et al (2015) Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat Commun 6:6044. https:\/\/doi.org\/10.1038\/ncomms7044","journal-title":"Nat Commun"},{"key":"9658_CR9","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","volume":"22","author":"RA Toledo","year":"2016","unstructured":"Toledo RA, Qin Y, Cheng Z-M, et al (2016) Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin cancer Res an Off J Am Assoc Cancer Res 22:2301\u20132310. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1841","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"9658_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/ERC-14-0016","volume":"21","author":"T Liu","year":"2014","unstructured":"Liu T, Brown TC, Juhlin CC, et al (2014) The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors. Endocr Relat Cancer 21:427\u2013434. https:\/\/doi.org\/10.1530\/ERC-14-0016","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/ERC-13-0429","volume":"21","author":"TG Papathomas","year":"2014","unstructured":"Papathomas TG, Oudijk L, Zwarthoff EC, et al (2014) Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia. Endocr Relat Cancer 21:653\u2013661. https:\/\/doi.org\/10.1530\/ERC-13-0429","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/gcc.22267","volume":"54","author":"CC Juhlin","year":"2015","unstructured":"Juhlin CC, Stenman A, Haglund F, et al (2015) Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene. Genes Chromosomes Cancer 54:542\u2013554. https:\/\/doi.org\/10.1002\/gcc.22267","journal-title":"Genes Chromosomes Cancer"},{"key":"9658_CR13","first-page":"1274","volume-title":"Histology for Pathologists","author":"AS Tischler","year":"2019","unstructured":"Tischler AS, Asa SL (2019) Paraganglia. In: Mills SE (ed) Histology for Pathologists, 5th ed. Lippincott Williams and Wilkins, Philadephia, PA, USA, pp 1274\u20131295","edition":"5"},{"key":"9658_CR14","doi-asserted-by":"publisher","unstructured":"Furlan A, Dyachuk V, Kastriti ME, et al (2017) Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science 357.\u00a0https:\/\/doi.org\/10.1126\/science.aal3753","DOI":"10.1126\/science.aal3753"},{"key":"9658_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fendo.2020.00079","volume":"11","author":"LD Scriba","year":"2020","unstructured":"Scriba LD, Bornstein SR, Santambrogio A, et al (2020) Cancer Stem Cells in Pheochromocytoma and Paraganglioma. Front Endocrinol (Lausanne) 11:79. https:\/\/doi.org\/10.3389\/fendo.2020.00079","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9658_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fnmol.2019.00006","volume":"12","author":"ME Kastriti","year":"2019","unstructured":"Kastriti ME, Kameneva P, Kamenev D, et al (2019) Schwann Cell Precursors Generate the Majority of Chromaffin Cells in Zuckerkandl Organ and Some Sympathetic Neurons in Paraganglia. Front Mol Neurosci 12:6. https:\/\/doi.org\/10.3389\/fnmol.2019.00006","journal-title":"Front Mol Neurosci"},{"issue":"Suppl","key":"9658_CR17","doi-asserted-by":"publisher","first-page":"S308","DOI":"10.1016\/j.ydbio.2018.05.016","volume":"444","author":"D Hockman","year":"2018","unstructured":"Hockman D, Adameyko I, Kaucka M, et al (2018) Striking parallels between carotid body glomus cell and adrenal chromaffin cell development. Dev Biol 444 Suppl:S308\u2013S324. https:\/\/doi.org\/10.1016\/j.ydbio.2018.05.016","journal-title":"Dev Biol"},{"key":"9658_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1101\/gad.1648608","volume":"22","author":"S Schlisio","year":"2008","unstructured":"Schlisio S, Kenchappa RS, Vredeveld LCW, et al (2008) The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 22:884\u2013893. https:\/\/doi.org\/10.1101\/gad.1648608","journal-title":"Genes Dev"},{"key":"9658_CR19","doi-asserted-by":"publisher","unstructured":"Dubard Gault M, Mandelker D, DeLair D, et al (2018) Germline SDHA mutations in children and adults with cancer. Cold Spring Harb Mol case Stud 4. https:\/\/doi.org\/10.1101\/mcs.a002584","DOI":"10.1101\/mcs.a002584"},{"key":"9658_CR20","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.3934\/mbe.2019362","volume":"16","author":"W Wu","year":"2019","unstructured":"Wu W, Xu WJ, Liu J Bin, et al (2019) Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma. Math Biosci Eng 16:7217\u20137229. https:\/\/doi.org\/10.3934\/mbe.2019362","journal-title":"Math Biosci Eng"},{"key":"9658_CR21","doi-asserted-by":"crossref","unstructured":"Pozza C, Sesti F, Di Dato C, et al (2020) A Novel MAX Gene Mutation Variant in a Patient With Multiple and \u201cComposite\u201d Neuroendocrine-Neuroblastic Tumors. Front. Endocrinol. (Lausanne). 11:234","DOI":"10.3389\/fendo.2020.00234"},{"key":"9658_CR22","unstructured":"Lloyd R V, Osamura RY, Kl\u00f6ppel G, Rosai J (2017) WHO Classification of Tumours of Endocrine Organs. International Agency for Research on Cancer"},{"key":"9658_CR23","doi-asserted-by":"publisher","first-page":"110998","DOI":"10.1016\/j.mce.2020.110998","volume":"518","author":"ME Kastriti","year":"2020","unstructured":"Kastriti ME, Kameneva P, Adameyko I (2020) Stem cells, evolutionary aspects and pathology of the adrenal medulla: A new developmental paradigm. Mol Cell Endocrinol 518:110998. https:\/\/doi.org\/10.1016\/j.mce.2020.110998","journal-title":"Mol Cell Endocrinol"},{"key":"9658_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/pl00008810","volume":"298","author":"K Langley","year":"1999","unstructured":"Langley K, Grant NJ (1999) Molecular markers of sympathoadrenal cells. Cell Tissue Res 298:185\u2013206. https:\/\/doi.org\/10.1007\/pl00008810","journal-title":"Cell Tissue Res"},{"key":"9658_CR25","doi-asserted-by":"publisher","unstructured":"Lee SE, Oh E, Lee B, et al (2016) Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma\/paraganglioma. Oncotarget 7:24141\u201324153. https:\/\/doi.org\/10.18632\/oncotarget.8234","DOI":"10.18632\/oncotarget.8234"},{"key":"9658_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00441-018-2795-0","volume":"372","author":"L Fishbein","year":"2018","unstructured":"Fishbein L, Wilkerson MD (2018) Chromaffin cell biology: inferences from The Cancer Genome Atlas. Cell Tissue Res 372:339\u2013346. https:\/\/doi.org\/10.1007\/s00441-018-2795-0","journal-title":"Cell Tissue Res"},{"key":"9658_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/onc.2015.172","volume":"35","author":"LJ Castro-Vega","year":"2016","unstructured":"Castro-Vega LJ, Lepoutre-Lussey C, Gimenez-Roqueplo A-P, Favier J (2016) Rethinking pheochromocytomas and paragangliomas from a genomic perspective. Oncogene 35:1080\u20131089. https:\/\/doi.org\/10.1038\/onc.2015.172","journal-title":"Oncogene"},{"key":"9658_CR28","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo A-P (2020) An overview of 20\u00a0years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 34:101416. https:\/\/doi.org\/10.1016\/j.beem.2020.101416","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9658_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","volume":"100","author":"S Pillai","year":"2016","unstructured":"Pillai S, Gopalan V, Smith RA, Lam AK-Y (2016) Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100:190\u2013208. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.022","journal-title":"Crit Rev Oncol Hematol"},{"key":"9658_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ecl.2017.01.009","volume":"46","author":"RA Toledo","year":"2017","unstructured":"Toledo RA (2017) Genetics of Pheochromocytomas and Paragangliomas: An Overview on the Recently Implicated Genes MERTK, MET, Fibroblast Growth Factor Receptor 1, and H3F3A. Endocrinol Metab Clin North Am 46:459\u2013489. https:\/\/doi.org\/10.1016\/j.ecl.2017.01.009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9658_CR31","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","volume":"23","author":"L Remacha","year":"2017","unstructured":"Remacha L, Comino-M\u00e9ndez I, Richter S, et al (2017) Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas. Clin cancer Res an Off J Am Assoc Cancer Res 23:6315\u20136324. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2250","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"9658_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00418-019-01772-w","volume":"151","author":"TG Papathomas","year":"2019","unstructured":"Papathomas TG, Sun N, Chortis V, et al (2019) Novel methods in adrenal research: a metabolomics approach. Histochem Cell Biol 151:201\u2013216. https:\/\/doi.org\/10.1007\/s00418-019-01772-w","journal-title":"Histochem Cell Biol"},{"key":"9658_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","volume":"21","author":"S Richter","year":"2019","unstructured":"Richter S, Gieldon L, Pang Y, et al (2019) Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma. Genet Med 21:705\u2013717. https:\/\/doi.org\/10.1038\/s41436-018-0106-5","journal-title":"Genet Med"},{"key":"9658_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymgmr.2016.12.006","volume":"10","author":"E Kim","year":"2017","unstructured":"Kim E, Wright MJ, Sioson L, et al (2017) Utility of the succinate: Fumarate ratio for assessing SDH dysfunction in different tumor types. Mol Genet Metab reports 10:45\u201349. https:\/\/doi.org\/10.1016\/j.ymgmr.2016.12.006","journal-title":"Mol Genet Metab reports"},{"key":"9658_CR35","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s00259-019-04633-9","volume":"47","author":"C Lussey-Lepoutre","year":"2020","unstructured":"Lussey-Lepoutre C, Bellucci A, Burnichon N, et al (2020) Succinate detection using in vivo (1)H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas. Eur J Nucl Med Mol Imaging 47:1510\u20131517. https:\/\/doi.org\/10.1007\/s00259-019-04633-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9658_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaoncol.2015.4771","volume":"2","author":"J Whitworth","year":"2016","unstructured":"Whitworth J, Skytte A-B, Sunde L, et al (2016) Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and Review. JAMA Oncol 2:373\u2013379. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4771","journal-title":"JAMA Oncol"},{"key":"9658_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/ncponc0935","volume":"4","author":"KM Zbuk","year":"2007","unstructured":"Zbuk KM, Patocs A, Shealy A, et al (2007) Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Nat Clin Pract Oncol 4:608\u2013612. https:\/\/doi.org\/10.1038\/ncponc0935","journal-title":"Nat Clin Pract Oncol"},{"key":"9658_CR38","doi-asserted-by":"publisher","unstructured":"Gieldon L, William D, Hackmann K, et al (2019) Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches. Cancers (Basel) 11. https:\/\/doi.org\/10.3390\/cancers11060809","DOI":"10.3390\/cancers11060809"},{"key":"9658_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajhg.2018.04.013","volume":"103","author":"J Whitworth","year":"2018","unstructured":"Whitworth J, Smith PS, Martin J-E, et al (2018) Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. Am J Hum Genet 103:3\u201318. https:\/\/doi.org\/10.1016\/j.ajhg.2018.04.013","journal-title":"Am J Hum Genet"},{"key":"9658_CR40","doi-asserted-by":"publisher","unstructured":"Gniado E, Carracher CP, Sharma S (2020) Simultaneous Occurrence of Germline Mutations of SDHB and TP53 in a Patient with Metastatic Pheochromocytoma. J Clin Endocrinol Metab 105. https:\/\/doi.org\/10.1210\/clinem\/dgz269","DOI":"10.1210\/clinem\/dgz269"},{"key":"9658_CR41","doi-asserted-by":"publisher","first-page":"138573","DOI":"10.1155\/2015\/138573","volume":"2015","author":"A Luchetti","year":"2015","unstructured":"Luchetti A, Walsh D, Rodger F, et al (2015) Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis. Int J Endocrinol 2015:138573. https:\/\/doi.org\/10.1155\/2015\/138573","journal-title":"Int J Endocrinol"},{"key":"9658_CR42","doi-asserted-by":"publisher","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","volume":"98","author":"J Crona","year":"2013","unstructured":"Crona J, Delgado Verdugo A, Maharjan R, et al (2013) Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J Clin Endocrinol Metab 98:E1266-71. https:\/\/doi.org\/10.1210\/jc.2012-4257","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR43","doi-asserted-by":"publisher","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","volume":"99","author":"L Oudijk","year":"2014","unstructured":"Oudijk L, de Krijger RR, Rapa I, et al (2014) H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series. J Clin Endocrinol Metab 99:E1376-80. https:\/\/doi.org\/10.1210\/jc.2013-3879","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/gcc.22347","volume":"55","author":"A Stenman","year":"2016","unstructured":"Stenman A, Welander J, Gustavsson I, et al (2016) HRAS mutation prevalence and associated expression patterns in pheochromocytoma. Genes Chromosomes Cancer 55:452\u2013459. https:\/\/doi.org\/10.1002\/gcc.22347","journal-title":"Genes Chromosomes Cancer"},{"key":"9658_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.4503","volume":"236","author":"A Flynn","year":"2015","unstructured":"Flynn A, Benn D, Clifton-Bligh R, et al (2015) The genomic landscape of phaeochromocytoma. J Pathol 236:78\u201389. https:\/\/doi.org\/10.1002\/path.4503","journal-title":"J Pathol"},{"key":"9658_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, et al (2017) Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31:181\u2013193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"key":"9658_CR47","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/ijc.29957","volume":"138","author":"A Wilz\u00e9n","year":"2016","unstructured":"Wilz\u00e9n A, Rehammar A, Muth A, et al (2016) Malignant pheochromocytomas\/paragangliomas harbor mutations in transport and cell adhesion genes. Int J cancer 138:2201\u20132211. https:\/\/doi.org\/10.1002\/ijc.29957","journal-title":"Int J cancer"},{"key":"9658_CR48","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","volume":"25","author":"S Job","year":"2019","unstructured":"Job S, Draskovic I, Burnichon N, et al (2019) Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma. Clin cancer Res an Off J Am Assoc Cancer Res 25:760\u2013770. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0139","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"9658_CR49","doi-asserted-by":"publisher","first-page":"e1008803","DOI":"10.1371\/journal.pgen.1008803","volume":"16","author":"TT Tomi\u0107","year":"2020","unstructured":"Tomi\u0107 TT, Olausson J, Rehammar A, et al (2020) MYO5B mutations in pheochromocytoma\/paraganglioma promote cancer progression. PLoS Genet 16:e1008803. https:\/\/doi.org\/10.1371\/journal.pgen.1008803","journal-title":"PLoS Genet"},{"key":"9658_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1210\/jc.2015-3856","volume":"101","author":"S Richter","year":"2016","unstructured":"Richter S, Klink B, Nacke B, et al (2016) Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. J Clin Endocrinol Metab 101:359\u2013363. https:\/\/doi.org\/10.1210\/jc.2015-3856","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1530\/ERC-14-0254","volume":"21","author":"F Haller","year":"2014","unstructured":"Haller F, Moskalev EA, Faucz FR, et al (2014) Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 21:567\u2013577. https:\/\/doi.org\/10.1530\/ERC-14-0254","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR52","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/ijc.32654","volume":"146","author":"S Ghosal","year":"2020","unstructured":"Ghosal S, Das S, Pang Y, et al (2020) Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker. Int J cancer 146:2326\u20132335. https:\/\/doi.org\/10.1002\/ijc.32654","journal-title":"Int J cancer"},{"key":"9658_CR53","doi-asserted-by":"publisher","unstructured":"Job S, Georges A, Burnichon N, et al (2020) Transcriptome Analysis of lncRNAs in Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab 105:.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgz168","DOI":"10.1210\/clinem\/dgz168"},{"key":"9658_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fgene.2020.00015","volume":"11","author":"A Yu","year":"2020","unstructured":"Yu A, Li M, Xing C, et al (2020) A Comprehensive Analysis Identified the Key Differentially Expressed Circular Ribonucleic Acids and Methylation-Related Function in Pheochromocytomas and Paragangliomas. Front Genet 11:15. https:\/\/doi.org\/10.3389\/fgene.2020.00015","journal-title":"Front Genet"},{"key":"9658_CR55","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.7150\/thno.35458","volume":"9","author":"B Calsina","year":"2019","unstructured":"Calsina B, Castro-Vega LJ, Torres-P\u00e9rez R, et al (2019) Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/mTOR axis in metastatic pheochromocytoma\/paraganglioma. Theranostics 9:4946\u20134958. https:\/\/doi.org\/10.7150\/thno.35458","journal-title":"Theranostics"},{"key":"9658_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14:108\u2013119. https:\/\/doi.org\/10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"key":"9658_CR57","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1210\/jc.2015-3889","volume":"101","author":"A Flynn","year":"2016","unstructured":"Flynn A, Dwight T, Harris J, et al (2016) Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 101:1034\u20131043. https:\/\/doi.org\/10.1210\/jc.2015-3889","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR58","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neo.2016.07.008","volume":"18","author":"SMJ Fliedner","year":"2016","unstructured":"Fliedner SMJ, Shankavaram U, Marzouca G, et al (2016) Hypoxia-Inducible Factor 2\u03b1 Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster. Neoplasia 18:567\u2013576. https:\/\/doi.org\/10.1016\/j.neo.2016.07.008","journal-title":"Neoplasia"},{"key":"9658_CR59","doi-asserted-by":"publisher","unstructured":"Letouz\u00e9 E, Martinelli C, Loriot C, et al (2013) SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma. Cancer Cell 23:739\u2013752. https:\/\/doi.org\/10.1016\/j.ccr.2013.04.018","DOI":"10.1016\/j.ccr.2013.04.018"},{"key":"9658_CR60","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","volume":"30","author":"A Morin","year":"2020","unstructured":"Morin A, Goncalves J, Moog S, et al (2020) TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2\u03b1-Driven Mesenchymal Transition. Cell Rep 30:4551-4566.e7. https:\/\/doi.org\/10.1016\/j.celrep.2020.03.022","journal-title":"Cell Rep"},{"key":"9658_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mce.2017.06.016","volume":"469","author":"P Bj\u00f6rklund","year":"2018","unstructured":"Bj\u00f6rklund P, Backman S (2018) Epigenetics of pheochromocytoma and paraganglioma. Mol Cell Endocrinol 469:92\u201397. https:\/\/doi.org\/10.1016\/j.mce.2017.06.016","journal-title":"Mol Cell Endocrinol"},{"key":"9658_CR62","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41374-017-0003-6","volume":"98","author":"I-M Schaefer","year":"2018","unstructured":"Schaefer I-M, Hornick JL, Bov\u00e9e JVMG (2018) The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms. Lab Invest 98:414\u2013426. https:\/\/doi.org\/10.1038\/s41374-017-0003-6","journal-title":"Lab Invest"},{"key":"9658_CR63","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/mc.22997","volume":"58","author":"K Ando","year":"2019","unstructured":"Ando K, Yokochi T, Mukai A, et al (2019) Tumor suppressor KIF1B\u03b2 regulates mitochondrial apoptosis in collaboration with YME1L1. Mol Carcinog 58:1134\u20131144. https:\/\/doi.org\/10.1002\/mc.22997","journal-title":"Mol Carcinog"},{"key":"9658_CR64","doi-asserted-by":"publisher","unstructured":"Crona J, Backman S, Welin S, et al (2018) RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective. Cancers (Basel) 10. https:\/\/doi.org\/10.3390\/cancers10120518","DOI":"10.3390\/cancers10120518"},{"key":"9658_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/ERC-11-0308","volume":"19","author":"E Patterson","year":"2012","unstructured":"Patterson E, Webb R, Weisbrod A, et al (2012) The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr Relat Cancer 19:157\u2013166. https:\/\/doi.org\/10.1530\/ERC-11-0308","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2017.03.017","volume":"64","author":"S Pillai","year":"2017","unstructured":"Pillai S, Lo CY, Liew V, et al (2017) MicroRNA 183 family profiles in pheochromocytomas are related to clinical parameters and SDHB expression. Hum Pathol 64:91\u201397. https:\/\/doi.org\/10.1016\/j.humpath.2017.03.017","journal-title":"Hum Pathol"},{"key":"9658_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.semdp.2013.06.006","volume":"30","author":"TG Papathomas","year":"2013","unstructured":"Papathomas TG, de Krijger RR, Tischler AS (2013) Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Semin Diagn Pathol 30:207\u2013223. https:\/\/doi.org\/10.1053\/j.semdp.2013.06.006","journal-title":"Semin Diagn Pathol"},{"key":"9658_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2015.05.011","volume":"43","author":"AS Hoekstra","year":"2015","unstructured":"Hoekstra AS, Devilee P, Bayley J-P (2015) Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Semin Cell Dev Biol 43:117\u2013124. https:\/\/doi.org\/10.1016\/j.semcdb.2015.05.011","journal-title":"Semin Cell Dev Biol"},{"key":"9658_CR69","doi-asserted-by":"publisher","first-page":"E2009","DOI":"10.1210\/jc.2011-1244","volume":"96","author":"PM Yeap","year":"2011","unstructured":"Yeap PM, Tobias ES, Mavraki E, et al (2011) Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. J Clin Endocrinol Metab 96:E2009-13. https:\/\/doi.org\/10.1210\/jc.2011-1244","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12881-014-0111-8","volume":"15","author":"J-P Bayley","year":"2014","unstructured":"Bayley J-P, Oldenburg RA, Nuk J, et al (2014) Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations. BMC Med Genet 15:111. https:\/\/doi.org\/10.1186\/s12881-014-0111-8","journal-title":"BMC Med Genet"},{"key":"9658_CR71","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-13-0146","volume":"20","author":"ER Maher","year":"2013","unstructured":"Maher ER (2013) HIF2 and endocrine neoplasia: an evolving story. Endocr Relat Cancer 20:C5-7. https:\/\/doi.org\/10.1530\/ERC-13-0146","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR72","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1210\/jc.2009-1156","volume":"94","author":"JA Carney","year":"2009","unstructured":"Carney JA (2009) Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. J Clin Endocrinol Metab 94:3656\u20133662. https:\/\/doi.org\/10.1210\/jc.2009-1156","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cancergencyto.2010.09.006","volume":"203","author":"MQ Almeida","year":"2010","unstructured":"Almeida MQ, Stratakis CA (2010) Solid tumors associated with multiple endocrine neoplasias. Cancer Genet Cytogenet 203:30\u201336. https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.09.006","journal-title":"Cancer Genet Cytogenet"},{"key":"9658_CR74","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ejhg.2015.142","volume":"24","author":"SA Boikos","year":"2016","unstructured":"Boikos SA, Xekouki P, Fumagalli E, et al (2016) Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet 24:569\u2013573. https:\/\/doi.org\/10.1038\/ejhg.2015.142","journal-title":"Eur J Hum Genet"},{"key":"9658_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2017.07.018","volume":"469","author":"N Settas","year":"2018","unstructured":"Settas N, Faucz FR, Stratakis CA (2018) Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome. Mol Cell Endocrinol 469:107\u2013111. https:\/\/doi.org\/10.1016\/j.mce.2017.07.018","journal-title":"Mol Cell Endocrinol"},{"key":"9658_CR76","doi-asserted-by":"publisher","unstructured":"Killian JK, Miettinen M, Walker RL, et al (2014) Recurrent epimutation of SDHC in gastrointestinal stromal tumors. Sci Transl Med 6:268ra177. https:\/\/doi.org\/10.1126\/scitranslmed.3009961","DOI":"10.1126\/scitranslmed.3009961"},{"key":"9658_CR77","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y, et al (2017) Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention. JAMA Oncol 3:1204\u20131212. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0223","journal-title":"JAMA Oncol"},{"key":"9658_CR78","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/cncr.31839","volume":"125","author":"Y Pang","year":"2019","unstructured":"Pang Y, Gupta G, Jha A, et al (2019) Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome. Cancer 125:1258\u20131266. https:\/\/doi.org\/10.1002\/cncr.31839","journal-title":"Cancer"},{"key":"9658_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo A-P (2015) Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11:101\u2013111. https:\/\/doi.org\/10.1038\/nrendo.2014.188","journal-title":"Nat Rev Endocrinol"},{"key":"9658_CR80","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/ERC-17-0325","volume":"25","author":"SAJ Wells","year":"2018","unstructured":"Wells SAJ (2018) Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors. Endocr Relat Cancer 25:T1\u2013T13. https:\/\/doi.org\/10.1530\/ERC-17-0325","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR81","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","volume":"13","author":"J Moline","year":"2011","unstructured":"Moline J, Eng C (2011) Multiple endocrine neoplasia type 2: an overview. Genet Med 13:755\u2013764. https:\/\/doi.org\/10.1097\/GIM.0b013e318216cc6d","journal-title":"Genet Med"},{"key":"9658_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc3680","volume":"14","author":"LM Mulligan","year":"2014","unstructured":"Mulligan LM (2014) RET revisited: expanding the oncogenic portfolio. Nat Rev Cancer 14:173\u2013186. https:\/\/doi.org\/10.1038\/nrc3680","journal-title":"Nat Rev Cancer"},{"key":"9658_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11886-019-1184-y","volume":"21","author":"L Fishbein","year":"2019","unstructured":"Fishbein L (2019) Pheochromocytoma\/Paraganglioma: Is This a Genetic Disorder? Curr Cardiol Rep 21:104. https:\/\/doi.org\/10.1007\/s11886-019-1184-y","journal-title":"Curr Cardiol Rep"},{"key":"9658_CR84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SAJ Wells","year":"2015","unstructured":"Wells SAJ, Asa SL, Dralle H, et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"9658_CR85","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"Castinetti F, Qi X-P, Walz MK, et al (2014) Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 15:648\u2013655. https:\/\/doi.org\/10.1016\/S1470-2045(14)70154-8","journal-title":"Lancet Oncol"},{"key":"9658_CR86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","volume":"23","author":"S Richard","year":"2013","unstructured":"Richard S, Gardie B, Couv\u00e9 S, Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol 23:26\u201337. https:\/\/doi.org\/10.1016\/j.semcancer.2012.05.005","journal-title":"Semin Cancer Biol"},{"key":"9658_CR87","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, et al (2003) von Hippel-Lindau disease. Lancet (London, England) 361:2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet (London, England)"},{"key":"9658_CR88","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","volume":"162","author":"MM Walther","year":"1999","unstructured":"Walther MM, Reiter R, Keiser HR, et al (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659\u2013664. https:\/\/doi.org\/10.1097\/00005392-199909010-00004","journal-title":"J Urol"},{"key":"9658_CR89","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 19:617\u2013623. https:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"Eur J Hum Genet"},{"key":"9658_CR90","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.path.2019.08.009","volume":"12","author":"J Guilmette","year":"2019","unstructured":"Guilmette J, Sadow PM (2019) A Guide to Pheochromocytomas and Paragangliomas. Surg Pathol Clin 12:951\u2013965. https:\/\/doi.org\/10.1016\/j.path.2019.08.009","journal-title":"Surg Pathol Clin"},{"key":"9658_CR91","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00268-005-0359-4","volume":"30","author":"KA Delman","year":"2006","unstructured":"Delman KA, Shapiro SE, Jonasch EW, et al (2006) Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg 30:665\u2013669. https:\/\/doi.org\/10.1007\/s00268-005-0359-4","journal-title":"World J Surg"},{"key":"9658_CR92","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, S\u00f6derkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253-76. https:\/\/doi.org\/10.1530\/ERC-11-0170","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","volume":"141","author":"M Lammert","year":"2005","unstructured":"Lammert M, Friedman JM, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141:71\u201374. https:\/\/doi.org\/10.1001\/archderm.141.1.71","journal-title":"Arch Dermatol"},{"key":"9658_CR94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cen.13163","volume":"86","author":"LM Gruber","year":"2017","unstructured":"Gruber LM, Erickson D, Babovic-Vuksanovic D, et al (2017) Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol (Oxf) 86:141\u2013149. https:\/\/doi.org\/10.1111\/cen.13163","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9658_CR95","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1056\/NEJMc066006","volume":"354","author":"B Bausch","year":"2006","unstructured":"Bausch B, Borozdin W, Neumann HPH (2006) Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N. Engl. J. Med. 354:2729\u20132731","journal-title":"N. Engl. J. Med."},{"key":"9658_CR96","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE, et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848\u2013851. https:\/\/doi.org\/10.1126\/science.287.5454.848","journal-title":"Science"},{"key":"9658_CR97","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, et al (2009) The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 94:2817\u20132827. https:\/\/doi.org\/10.1210\/jc.2008-2504","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/jmedgenet-2016-104297","volume":"54","author":"N Burnichon","year":"2017","unstructured":"Burnichon N, Mazzella J-M, Drui D, et al (2017) Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma. J Med Genet 54:125\u2013133. https:\/\/doi.org\/10.1136\/jmedgenet-2016-104297","journal-title":"J Med Genet"},{"key":"9658_CR99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","volume":"266","author":"B Pasini","year":"2009","unstructured":"Pasini B, Stratakis CA (2009) SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266:19\u201342. https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02111.x","journal-title":"J Intern Med"},{"key":"9658_CR100","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1053\/j.seminoncol.2010.10.017","volume":"37","author":"SMJ Fliedner","year":"2010","unstructured":"Fliedner SMJ, Lehnert H, Pacak K (2010) Metastatic paraganglioma. Semin Oncol 37:627\u2013637. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.10.017","journal-title":"Semin Oncol"},{"key":"9658_CR101","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1210\/jc.2017-01762","volume":"103","author":"K van der Tuin","year":"2018","unstructured":"van der Tuin K, Mensenkamp AR, Tops CMJ, et al (2018) Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study. J Clin Endocrinol Metab 103:438\u2013445. https:\/\/doi.org\/10.1210\/jc.2017-01762","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR102","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, et al (2018) Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet 55:384\u2013394. https:\/\/doi.org\/10.1136\/jmedgenet-2017-105127","journal-title":"J Med Genet"},{"key":"9658_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2019.00053","volume":"9","author":"A Jha","year":"2019","unstructured":"Jha A, de Luna K, Balili CA, et al (2019) Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma. Front Oncol 9:53. https:\/\/doi.org\/10.3389\/fonc.2019.00053","journal-title":"Front Oncol"},{"key":"9658_CR104","doi-asserted-by":"publisher","first-page":"T201","DOI":"10.1530\/ERC-18-0085","volume":"25","author":"HP Neumann","year":"2018","unstructured":"Neumann HP, Young WFJ, Krauss T, et al (2018) 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer 25:T201\u2013T219. https:\/\/doi.org\/10.1530\/ERC-18-0085","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR105","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM197706302962609","volume":"296","author":"JA Carney","year":"1977","unstructured":"Carney JA, Sheps SG, Go VL, Gordon H (1977) The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 296:1517\u20131518. https:\/\/doi.org\/10.1056\/NEJM197706302962609","journal-title":"N Engl J Med"},{"key":"9658_CR106","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ajmg.10235","volume":"108","author":"JA Carney","year":"2002","unstructured":"Carney JA, Stratakis CA (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 108:132\u2013139. https:\/\/doi.org\/10.1002\/ajmg.10235","journal-title":"Am J Med Genet"},{"key":"9658_CR107","first-page":"203","volume":"19","author":"O Daum","year":"2006","unstructured":"Daum O, Vanecek T, Sima R, Michal M (2006) Gastrointestinal stromal tumor: update. Klin Onkol 19:203\u2013211","journal-title":"Gastrointestinal stromal tumor: update. Klin Onkol"},{"key":"9658_CR108","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","volume":"23","author":"LJ Castro-Vega","year":"2014","unstructured":"Castro-Vega LJ, Buffet A, De Cubas AA, et al (2014) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23:2440\u20132446. https:\/\/doi.org\/10.1093\/hmg\/ddt639","journal-title":"Hum Mol Genet"},{"key":"9658_CR109","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","volume":"99","author":"GR Clark","year":"2014","unstructured":"Clark GR, Sciacovelli M, Gaude E, et al (2014) Germline FH mutations presenting with pheochromocytoma. J Clin Endocrinol Metab 99:E2046-50. https:\/\/doi.org\/10.1210\/jc.2014-1659","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR110","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh Q-Y, Eisenhofer G, et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942. https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR111","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, et al (2016) European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174:G1\u2013G10. https:\/\/doi.org\/10.1530\/EJE-16-0033","journal-title":"Eur J Endocrinol"},{"key":"9658_CR112","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.185","volume":"13","author":"RA Toledo","year":"2017","unstructured":"Toledo RA, Burnichon N, Cascon A, et al (2017) Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13:233\u2013247. https:\/\/doi.org\/10.1038\/nrendo.2016.185","journal-title":"Nat Rev Endocrinol"},{"key":"9658_CR113","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-anchem-062012-092628","volume":"6","author":"ER Mardis","year":"2013","unstructured":"Mardis ER (2013) Next-generation sequencing platforms. Annu Rev Anal Chem (Palo Alto Calif) 6:287\u2013303. https:\/\/doi.org\/10.1146\/annurev-anchem-062012-092628","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"9658_CR114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.critrevonc.2017.05.005","volume":"116","author":"S Pillai","year":"2017","unstructured":"Pillai S, Gopalan V, Lam AK-Y (2017) Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas. Crit Rev Oncol Hematol 116:58\u201367. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.05.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"9658_CR115","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","volume":"99","author":"J Welander","year":"2014","unstructured":"Welander J, Andreasson A, Juhlin CC, et al (2014) Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 99:E1352\u2013E1360. https:\/\/doi.org\/10.1210\/jc.2013-4375","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR116","doi-asserted-by":"publisher","unstructured":"Liu P, Li M, Guan X, et al (2018) Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma. J kidney cancer VHL 5:14\u201322. https:\/\/doi.org\/10.15586\/jkcvhl.2018.113","DOI":"10.15586\/jkcvhl.2018.113"},{"key":"9658_CR117","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.seminhematol.2014.08.003","volume":"51","author":"ER Mardis","year":"2014","unstructured":"Mardis ER (2014) Sequencing the AML genome, transcriptome, and epigenome. Semin Hematol 51:250\u2013258. https:\/\/doi.org\/10.1053\/j.seminhematol.2014.08.003","journal-title":"Semin Hematol"},{"key":"9658_CR118","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/gb-2010-11-6-r62","volume":"11","author":"MN Bainbridge","year":"2010","unstructured":"Bainbridge MN, Wang M, Burgess DL, et al (2010) Whole exome capture in solution with 3 Gbp of data. Genome Biol 11:R62. https:\/\/doi.org\/10.1186\/gb-2010-11-6-r62","journal-title":"Genome Biol"},{"key":"9658_CR119","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/gb-2011-12-9-r97","volume":"12","author":"JS Parla","year":"2011","unstructured":"Parla JS, Iossifov I, Grabill I, et al (2011) A comparative analysis of exome capture. Genome Biol 12:R97. https:\/\/doi.org\/10.1186\/gb-2011-12-9-r97","journal-title":"Genome Biol"},{"key":"9658_CR120","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106519","author":"A Buffet","year":"2020","unstructured":"Buffet A, Calsina B, Flores S, et al (2020) Germline mutations in the new E1\u2019 cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma. J Med Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106519","journal-title":"J Med Genet"},{"key":"9658_CR121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-genom-082509-141536","volume":"11","author":"PA Cowin","year":"2010","unstructured":"Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DDL (2010) Profiling the Cancer Genome. Annu Rev Genomics Hum Genet 11:133\u2013159. https:\/\/doi.org\/10.1146\/annurev-genom-082509-141536","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"9658_CR122","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683\u2013692. https:\/\/doi.org\/10.1016\/j.cell.2007.01.029","journal-title":"Cell"},{"key":"9658_CR123","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nm.2305","volume":"17","author":"M Rodr\u00edguez-Paredes","year":"2011","unstructured":"Rodr\u00edguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17:330\u2013339. https:\/\/doi.org\/10.1038\/nm.2305","journal-title":"Nat Med"},{"key":"9658_CR124","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","volume":"21","author":"AA de Cubas","year":"2015","unstructured":"de Cubas AA, Korpershoek E, Inglada-P\u00e9rez L, et al (2015) DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers. Clin cancer Res an Off J Am Assoc Cancer Res 21:3020\u20133030. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2804","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"9658_CR125","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK-Y Lam","year":"2017","unstructured":"Lam AK-Y (2017) Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol 28:213\u2013227. https:\/\/doi.org\/10.1007\/s12022-017-9484-5","journal-title":"Endocr Pathol"},{"key":"9658_CR126","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-M\u00e9ndez","year":"2011","unstructured":"Comino-M\u00e9ndez I, Gracia-Azn\u00e1rez FJ, Schiavi F, et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663\u2013667. https:\/\/doi.org\/10.1038\/ng.861","journal-title":"Nat Genet"},{"key":"9658_CR127","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","volume":"78","author":"A Buffet","year":"2018","unstructured":"Buffet A, Morin A, Castro-Vega L-J, et al (2018) Germline Mutations in the Mitochondrial 2-Oxoglutarate\/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas. Cancer Res 78:1914\u20131922. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2463","journal-title":"Cancer Res"},{"key":"9658_CR128","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-19-0435","volume":"27","author":"PLM Dahia","year":"2020","unstructured":"Dahia PLM, Clifton-Bligh R, Gimenez-Roqueplo A-P, et al (2020) HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop. Endocr Relat Cancer 27:T41\u2013T52. https:\/\/doi.org\/10.1530\/ERC-19-0435","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR129","doi-asserted-by":"publisher","unstructured":"Mei L, Khurana A, Al-Juhaishi T, et al (2019) Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review. Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab 51:451\u2013457. https:\/\/doi.org\/10.1055\/a-0851-3275","DOI":"10.1055\/a-0851-3275"},{"key":"9658_CR130","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41436-018-0068-7","volume":"20","author":"B Calsina","year":"2018","unstructured":"Calsina B, Curr\u00e1s-Freixes M, Buffet A, et al (2018) Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients. Genet Med 20:1652\u20131662. https:\/\/doi.org\/10.1038\/s41436-018-0068-7","journal-title":"Genet Med"},{"key":"9658_CR131","doi-asserted-by":"publisher","unstructured":"Casc\u00f3n A, Remacha L, Calsina B, Robledo M (2019) Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration. Cancers (Basel) 11. https:\/\/doi.org\/10.3390\/cancers11050683","DOI":"10.3390\/cancers11050683"},{"key":"9658_CR132","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmedgenet-2019-106324","volume":"57","author":"H Lee","year":"2020","unstructured":"Lee H, Jeong S, Yu Y, et al (2020) Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis. J Med Genet 57:217\u2013225. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106324","journal-title":"J Med Genet"},{"key":"9658_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-17-0306","volume":"25","author":"T Dwight","year":"2018","unstructured":"Dwight T, Flynn A, Amarasinghe K, et al (2018) TERT structural rearrangements in metastatic pheochromocytomas. Endocr Relat Cancer 25:1\u20139. https:\/\/doi.org\/10.1530\/ERC-17-0306","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR134","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WFJ, I\u00f1iguez-Ariza NM, et al (2017) Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years. J Clin Endocrinol Metab 102:3296\u20133305. https:\/\/doi.org\/10.1210\/jc.2017-00992","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR135","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MED.0000000000000476","volume":"26","author":"O Hamidi","year":"2019","unstructured":"Hamidi O (2019) Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management. Curr Opin Endocrinol Diabetes Obes 26:146\u2013154. https:\/\/doi.org\/10.1097\/MED.0000000000000476","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"9658_CR136","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/cen.13434","volume":"87","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WFJ, Gruber L, et al (2017) Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 87:440\u2013450. https:\/\/doi.org\/10.1111\/cen.13434","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9658_CR137","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2018-01968","volume":"104","author":"S Hescot","year":"2019","unstructured":"Hescot S, Curras-Freixes M, Deutschbein T, et al (2019) Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. J Clin Endocrinol Metab 104:2367\u20132374. https:\/\/doi.org\/10.1210\/jc.2018-01968","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR138","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/SLA.0000000000002195","volume":"268","author":"A Roman-Gonzalez","year":"2018","unstructured":"Roman-Gonzalez A, Zhou S, Ayala-Ramirez M, et al (2018) Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg 268:172\u2013178. https:\/\/doi.org\/10.1097\/SLA.0000000000002195","journal-title":"Ann Surg"},{"key":"9658_CR139","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","volume":"143","author":"I Jochmanova","year":"2017","unstructured":"Jochmanova I, Wolf KI, King KS, et al (2017) SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. J Cancer Res Clin Oncol 143:1421\u20131435. https:\/\/doi.org\/10.1007\/s00432-017-2397-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"9658_CR140","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/jc.2010-1588","volume":"96","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Timmers HJ, Lenders JWM, et al (2011) Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab 96:375\u2013384. https:\/\/doi.org\/10.1210\/jc.2010-1588","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR141","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, et al (2019) Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer 26:539\u2013550. https:\/\/doi.org\/10.1530\/ERC-19-0024","journal-title":"Endocr Relat Cancer"},{"key":"9658_CR142","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ando.2019.04.003","volume":"80","author":"J Goncalves","year":"2019","unstructured":"Goncalves J, Lussey-Lepoutre C, Favier J, et al (2019) Emerging molecular markers of metastatic pheochromocytomas and paragangliomas. Ann Endocrinol (Paris) 80:159\u2013162. https:\/\/doi.org\/10.1016\/j.ando.2019.04.003","journal-title":"Ann Endocrinol (Paris)"},{"key":"9658_CR143","doi-asserted-by":"publisher","first-page":"44943","DOI":"10.1038\/srep44943","volume":"7","author":"S Backman","year":"2017","unstructured":"Backman S, Maharjan R, Falk-Delgado A, et al (2017) Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations. Sci Rep 7:44943. https:\/\/doi.org\/10.1038\/srep44943","journal-title":"Sci Rep"},{"key":"9658_CR144","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmoldx.2020.04.205","volume":"22","author":"L de Vos","year":"2020","unstructured":"de Vos L, Jung M, Koerber R-M, et al (2020) Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study. J Mol Diagn 22:920\u2013933. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.04.205","journal-title":"J Mol Diagn"},{"key":"9658_CR145","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00428-015-1834-4","volume":"468","author":"DW Ellis","year":"2016","unstructured":"Ellis DW, Srigley J (2016) Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets. Virchows Arch 468:51\u201359. https:\/\/doi.org\/10.1007\/s00428-015-1834-4","journal-title":"Virchows Arch"},{"key":"9658_CR146","volume-title":"Phaeochromocytoma and Paraganglioma Histopathology Reporting Guide","author":"A Tischler","year":"2019","unstructured":"Tischler A, Asa S, Clifton-Bligh R, et al (2019) Phaeochromocytoma and Paraganglioma Histopathology Reporting Guide. Sydney, Australia"},{"key":"9658_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.04.012","author":"LDR Thompson","year":"2020","unstructured":"Thompson LDR, Gill AJ, Asa SL, et al (2020) Data set for the reporting of pheochromocytoma and paraganglioma\u202f: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting *. Hum Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2020.04.012","journal-title":"Hum Pathol"},{"key":"9658_CR148","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LDR Thompson","year":"2002","unstructured":"Thompson LDR (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551\u2013566. https:\/\/doi.org\/10.1097\/00000478-200205000-00002","journal-title":"Am J Surg Pathol"},{"key":"9658_CR149","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0494","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, et al (2014) Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. https:\/\/doi.org\/10.1530\/ERC-13-0494","journal-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma."},{"key":"9658_CR150","doi-asserted-by":"publisher","unstructured":"Wachtel H, Hutchens T, Baraban E, et al (2020) Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems. J Clin Endocrinol Metab 105. https:\/\/doi.org\/10.1210\/clinem\/dgaa608","DOI":"10.1210\/clinem\/dgaa608"},{"key":"9658_CR151","doi-asserted-by":"publisher","unstructured":"Stenman A, Zedenius J, Juhlin CC (2019) The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas \u2014 A Meta-Analysis and Systematic Review of the Literature.\u00a0https:\/\/doi.org\/10.3390\/cancers11020225","DOI":"10.3390\/cancers11020225"},{"key":"9658_CR152","unstructured":"Amin MB, Edge S, Greene F, et al (2017) AJCC Cancer Staging Manual, 8th ed. Springer International Publishing"},{"key":"9658_CR153","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/PAP.0000000000000227","volume":"26","author":"TG Papathomas","year":"2019","unstructured":"Papathomas TG, Nos\u00e9 V (2019) New and Emerging Biomarkers in Endocrine Pathology. Adv Anat Pathol 26:198\u2013209. https:\/\/doi.org\/10.1097\/PAP.0000000000000227","journal-title":"Adv Anat Pathol"},{"key":"9658_CR154","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1242\/dev.02553","volume":"133","author":"T Moriguchi","year":"2006","unstructured":"Moriguchi T, Takako N, Hamada M, et al (2006) Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development 133:3871\u20133881. https:\/\/doi.org\/10.1242\/dev.02553","journal-title":"Development"},{"key":"9658_CR155","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01607135","volume":"421","author":"N Kimura","year":"1992","unstructured":"Kimura N, Miura Y, Nagatsu I, Nagura H (1992) Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421:25\u201332. https:\/\/doi.org\/10.1007\/BF01607135","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"9658_CR156","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/apm.12269","volume":"122","author":"R Pai","year":"2014","unstructured":"Pai R, Manipadam MT, Singh P, et al (2014) Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes. APMIS 122:1130\u20131135. https:\/\/doi.org\/10.1111\/apm.12269","journal-title":"APMIS"},{"key":"9658_CR157","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","volume":"1","author":"PLM Dahia","year":"2005","unstructured":"Dahia PLM, Ross KN, Wright ME, et al (2005) A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:72\u201380. https:\/\/doi.org\/10.1371\/journal.pgen.0010008","journal-title":"PLoS Genet"},{"key":"9658_CR158","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon N, Bri\u00e8re J-J, Lib\u00e9 R, et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011\u20133020. https:\/\/doi.org\/10.1093\/hmg\/ddq206","journal-title":"Hum Mol Genet"},{"key":"9658_CR159","doi-asserted-by":"publisher","unstructured":"Papathomas TG, Oudijk L, Persu A, et al (2015) SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Mod Pathol an Off J United States Can Acad Pathol Inc 28:807\u2013821. https:\/\/doi.org\/10.1038\/modpathol.2015.41","DOI":"10.1038\/modpathol.2015.41"},{"key":"9658_CR160","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH van Nederveen","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J, et al (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764\u2013771. https:\/\/doi.org\/10.1016\/S1470-2045(09)70164-0","journal-title":"Lancet Oncol"},{"key":"9658_CR161","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1210\/jc.2014-1870","volume":"100","author":"M Menara","year":"2015","unstructured":"Menara M, Oudijk L, Badoual C, et al (2015) SDHD Immunohistochemistry: A New Tool to Validate SDHx Mutations in Pheochromocytoma\/Paraganglioma. J Clin Endocrinol Metab 100:E287\u2013E291. https:\/\/doi.org\/10.1210\/jc.2014-1870","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR162","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.5858\/arpa.2018-0216-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Dhanasekaran SM, Mehra R (2018) Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma. Arch Pathol Lab Med 142:1202\u20131215. https:\/\/doi.org\/10.5858\/arpa.2018-0216-RA","journal-title":"Arch Pathol Lab Med"},{"key":"9658_CR163","doi-asserted-by":"publisher","unstructured":"Favier J, Meatchi T, Robidel E, et al (2020) Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study. Mod Pathol an Off J United States Can Acad Pathol Inc 33:57\u201364. https:\/\/doi.org\/10.1038\/s41379-019-0343-4","DOI":"10.1038\/s41379-019-0343-4"},{"key":"9658_CR164","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2015-2592","volume":"101","author":"E Korpershoek","year":"2016","unstructured":"Korpershoek E, Koffy D, Eussen BH, et al (2016) Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis. J Clin Endocrinol Metab 101:453\u2013460. https:\/\/doi.org\/10.1210\/jc.2015-2592","journal-title":"J Clin Endocrinol Metab"},{"key":"9658_CR165","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12022-018-9534-7","volume":"29","author":"VKY Cheung","year":"2018","unstructured":"Cheung VKY, Gill AJ, Chou A (2018) Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma. Endocr Pathol 29:169\u2013175. https:\/\/doi.org\/10.1007\/s12022-018-9534-7","journal-title":"Endocr Pathol"},{"key":"9658_CR166","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12022-014-9348-1","volume":"26","author":"A Stenman","year":"2015","unstructured":"Stenman A, Svahn F, Welander J, et al (2015) Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma. Endocr Pathol 26:9\u201314. https:\/\/doi.org\/10.1007\/s12022-014-9348-1","journal-title":"Endocr Pathol"},{"key":"9658_CR167","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1385\/ep:14:4:351","volume":"14","author":"JF Powers","year":"2003","unstructured":"Powers JF, Brachold JM, Tischler AS (2003) Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma. Endocr Pathol 14:351\u2013361. https:\/\/doi.org\/10.1385\/ep:14:4:351","journal-title":"Endocr Pathol"},{"key":"9658_CR168","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12022-019-09595-0","volume":"30","author":"V Maffeis","year":"2019","unstructured":"Maffeis V, Cappellesso R, Nicol\u00e8 L, et al (2019) Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations. Endocr Pathol 30:276\u2013284. https:\/\/doi.org\/10.1007\/s12022-019-09595-0","journal-title":"Endocr Pathol"},{"key":"9658_CR169","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/path.5472","volume":"251","author":"PW Wallace","year":"2020","unstructured":"Wallace PW, Conrad C, Br\u00fcckmann S, et al (2020) Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas. J Pathol 251:378\u2013387. https:\/\/doi.org\/10.1002\/path.5472","journal-title":"J Pathol"},{"key":"9658_CR170","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/PAS.0000000000001190","volume":"43","author":"A Stenman","year":"2019","unstructured":"Stenman A, Svahn F, Hojjat-Farsangi M, et al (2019) Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior. Am J Surg Pathol 43:409\u2013421. https:\/\/doi.org\/10.1097\/PAS.0000000000001190","journal-title":"Am J Surg Pathol"},{"key":"9658_CR171","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","volume":"36","author":"M K\u00f6rner","year":"2012","unstructured":"K\u00f6rner M, Waser B, Schonbrunn A, et al (2012) Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol 36:242\u2013252. https:\/\/doi.org\/10.1097\/PAS.0b013e31823d07f3","journal-title":"Am J Surg Pathol"},{"key":"9658_CR172","doi-asserted-by":"publisher","first-page":"10775","DOI":"10.1038\/srep10775","volume":"5","author":"A Koussounadis","year":"2015","unstructured":"Koussounadis A, Langdon SP, Um IH, et al (2015) Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci Rep 5:10775. https:\/\/doi.org\/10.1038\/srep10775","journal-title":"Sci Rep"},{"key":"9658_CR173","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41574-020-00413-w","volume":"16","author":"K Pacak","year":"2020","unstructured":"Pacak K, Eisenhofer G, Tischler AS (2020) Phaeochromocytoma - advances through science, collaboration and spreading the word. Nat Rev Endocrinol 16:621\u2013622. https:\/\/doi.org\/10.1038\/s41574-020-00413-w","journal-title":"Nat Rev Endocrinol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-020-09658-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T08:56:46Z","timestamp":1615798606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-020-09658-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9658"],"URL":"https:\/\/doi.org\/10.1007\/s12022-020-09658-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"9 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All authors consent to participate in this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors consent to the publication of this review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}